SE446338B - 2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat - Google Patents

2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat

Info

Publication number
SE446338B
SE446338B SE7902661A SE7902661A SE446338B SE 446338 B SE446338 B SE 446338B SE 7902661 A SE7902661 A SE 7902661A SE 7902661 A SE7902661 A SE 7902661A SE 446338 B SE446338 B SE 446338B
Authority
SE
Sweden
Prior art keywords
pyrazinylmethyl
compound
formula
pyrazine
methyl
Prior art date
Application number
SE7902661A
Other languages
English (en)
Swedish (sv)
Other versions
SE7902661L (sv
Inventor
P Cozzi
O Magni
L Bertone
R Angelucci
P P Lovisolo
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE7902661L publication Critical patent/SE7902661L/xx
Publication of SE446338B publication Critical patent/SE446338B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16Halogen atoms; Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7902661A 1978-03-23 1979-03-23 2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat SE446338B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21520/78A IT1094287B (it) 1978-03-23 1978-03-23 Derivati della 2-idrossimetil-pirazina aventi attivita' ipolipemizzante

Publications (2)

Publication Number Publication Date
SE7902661L SE7902661L (sv) 1979-09-24
SE446338B true SE446338B (sv) 1986-09-01

Family

ID=11183025

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7902661A SE446338B (sv) 1978-03-23 1979-03-23 2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat

Country Status (13)

Country Link
US (1) US4267327A (fi)
JP (1) JPS5531063A (fi)
BE (1) BE875013A (fi)
CA (1) CA1146171A (fi)
CH (1) CH642639A5 (fi)
DE (1) DE2910824A1 (fi)
DK (1) DK151254C (fi)
FR (2) FR2448536A1 (fi)
GB (1) GB2017691B (fi)
IT (1) IT1094287B (fi)
NL (1) NL7902268A (fi)
SE (1) SE446338B (fi)
ZA (1) ZA791047B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406901A (en) * 1980-02-06 1983-09-27 Farmitalia Carlo Erba S.P.A. Ethers of substituted hydroxymethylpyrazines
IL64267A (en) * 1980-12-09 1985-08-30 Erba Farmitalia Ethers of hydroxymethylpyrazin-n-oxides,their preparation and pharmaceutical compositions containing them
JPS59219269A (ja) * 1983-05-30 1984-12-10 Terumo Corp ピラジン誘導体を有効成分とする血小板凝集抑制剤
DE3433960A1 (de) * 1984-09-15 1986-03-27 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-amino-3-cyano-5-dialkoxymehtyl-pyrazinen und zwischenprodukte fuer diese verfahren
JPS63135216U (fi) * 1987-02-27 1988-09-05
CN101684102B (zh) * 2008-09-28 2013-06-05 安徽省新星药物开发有限责任公司 苯氧乙酸吡嗪酯类衍生物及其制法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU470007B2 (en) * 1972-04-28 1976-02-26 Farmitalia Carlo Erba S.R.L. Pyrazine 4-oxide derivatives and process for their preparation
US4002750A (en) * 1972-04-28 1977-01-11 Carlo Erba S.P.A. Pyrazine 4-oxide derivatives and process for their preparation
US4051245A (en) * 1972-04-28 1977-09-27 Carlo Erba, S.P.A. Pyrazine 4-oxide derivatives and process for their preparation

Also Published As

Publication number Publication date
FR2448536A1 (fr) 1980-09-05
FR2448536B1 (fi) 1983-01-28
FR2445144B1 (fi) 1983-03-25
BE875013A (fr) 1979-09-24
FR2445144A1 (fr) 1980-07-25
DK118879A (da) 1979-09-24
DK151254B (da) 1987-11-16
DK151254C (da) 1988-07-04
ZA791047B (en) 1980-03-26
CH642639A5 (de) 1984-04-30
NL7902268A (nl) 1979-09-25
JPS6310697B2 (fi) 1988-03-08
GB2017691A (en) 1979-10-10
GB2017691B (en) 1982-06-16
DE2910824C2 (fi) 1989-06-22
US4267327A (en) 1981-05-12
CA1146171A (en) 1983-05-10
DE2910824A1 (de) 1979-09-27
SE7902661L (sv) 1979-09-24
IT7821520A0 (it) 1978-03-23
IT1094287B (it) 1985-07-26
JPS5531063A (en) 1980-03-05

Similar Documents

Publication Publication Date Title
US4166861A (en) Pharmacologically active polyphenolic substances
IE52118B1 (en) Imidazole derivatives,preparation thereof and pharmaceutical preparations containing them
US4472411A (en) 1,4-Dihydropyridine derivatives and use as vasodilators
US3984413A (en) Phenoxyalkanecarboxylic acid esters of hydroxyalkyltheophyllines and method for their manufacture
SE446338B (sv) 2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat
US3268582A (en) Phenylalkyl-carboxylic acid amides
EP0096890B1 (en) Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives
NO127149B (fi)
US4218446A (en) Substituted steroid-spiro-oxazolidinone derivatives and a process for the preparation thereof
US4278678A (en) Substituted oxy-cyclohexylacetic acid derivatives
US3272832A (en) Nicotinic acid derivatives and process for the preparation thereof
US3658967A (en) Carboxylic acid derivatives for lowering the concentration of triglycerides in the blood
JPH0631228B2 (ja) 新規な5―(ω―アンモニオアシルオキシメチレン)テトラヒドロフラン類及びテトラヒドロチオフェン類、それらの製造法並びにそれらを含有する抗PAF剤
US4120963A (en) Certain pyrido[3,4-b]indole-1-ones
NO154840B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte 2-amino-3,4-dihydropyridinderivater.
US4148898A (en) N-oxy-ajmaline and the use thereof in treating cardiovascular disorders
DE1941933C3 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-SH-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4820837A (en) 1-hydroxy-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid esters
SE456579B (sv) Etrar av substituerade hydroximetylpyraziner, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa
US3991188A (en) 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions
US3989745A (en) Benzoyl-benzoic acid derivatives
JPH062748B2 (ja) 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
GB2200629A (en) A substituted 1, 2, 3, 4-tetrahydropyrimidine, and preparation and use thereof
US4292314A (en) Cardioactive 12-dehydrodigoxin-oximes
US4661618A (en) 1-3,bis(dimethylamino)-2-propyl-4-chlorophenoxy-acetate, acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7902661-3

Effective date: 19921005

Format of ref document f/p: F